US20180057507A1

Inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease

University of Texas System

Abstract

Disclosed herein are compounds which inhibit the kinase activity of dual leucine zipper (DLK) kinase (MAP3K12), pharmaceutical compositions, and methods of treatment of DLK-mediated diseases, such as neurological diseases that result from traumatic injury to central nervous system and peripheral …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Michael J. Soth
Priority date: August 29, 2016
Filing date: August 28, 2017
Publication date: March 01, 2018
Language: en
PDF source: https://patentimages.storage.googleapis.com/e3/10/b7/310a98e550b016/US20180057507A1.pdf
Metadata fetched: August 29, 2026 00:25